Developer of a botulinum toxin liquid formulation designed to bring a new anti-aging and medical experience characterized by efficacy. Revelyx Bio is based in DE and was founded in 2025. Its last reported valuation was $110 million in Jan 2026. It has raised $10.4 million.
Last reported valuation
$109.5M
Oct 2026
Priced at
—
Total raised
$10.4M
Last round
—
Team — not yet on record
No current team members for Revelyx Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Revelyx Bio with a free account
·Watch Revelyx Bio: the Monday email on marks, rounds and moves
